Cargando…

1458. Burden of Illness in Patients with Urinary Tract Infections With or Without Bacteremia Caused by Carbapenem-Resistant Gram-Negative Pathogens in US Hospitals (2014 to 2018)

BACKGROUND: Urinary tract infections (UTIs) are the most frequent infections caused by Gram-negative (GNB) bacteria in the USA. We aimed to characterize the burden of UTIs caused by carbapenem-resistant (CR) or -susceptible (CS) GNB in hospitalized patients with or without bacteremia. METHODS: Data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shields, Ryan K, Kanakamedala, Hemanth, Zhou, Yun, Cai, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809860/ http://dx.doi.org/10.1093/ofid/ofz360.1322

Ejemplares similares

Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia
por: Shields, Ryan K., et al.
Publicado: (2021)

551. Burden of Illness in Carbapenem-Resistant Acinetobacter baumannii Infections in US Hospitals (2014 to 2018)
por: Pogue, Jason M, et al.
Publicado: (2019)

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019
por: Pogue, Jason M., et al.
Publicado: (2022)

842. Impact of Active Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in US Hospitals Between 2014 and 2019
por: Pogue, Jason M, et al.
Publicado: (2020)

848. Trends of Carbapenem Resistance in Enterobacterales in the US Between 2015 and 2019
por: Marcella, Stephen, et al.
Publicado: (2020)

Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections
por: McCann, Eilish, et al.
Publicado: (2020)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

150. Urinary Tract-Associated Gram-Negative Bacteremia: Impact of Treatment Duration
por: Badwal, Jasmin K, et al.
Publicado: (2019)

164. Analysis of Adult, Hospitalized Patients With Carbapenem-resistant (CR) Gram-Negative Bloodstream Infections (GN-BSIs) due to Lactose Fermenters (LFs) and Non-lactose Fermenters (NLFs): Is There a Difference in Outcomes?
por: Lodise, Thomas, et al.
Publicado: (2019)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

In Vivo Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Murine Urinary Tract Infection Models
por: Matsumoto, Shuhei, et al.
Publicado: (2017)

Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
por: Shi, Hye Jin, et al.
Publicado: (2020)

1,4,5,8-Tetraisopropylanthracene
por: Kitamura, Chitoshi, et al.
Publicado: (2010)

1041 Economic Burden Associated with Key Gram-negative Pathogens among Patients with Complicated Urinary Tract Infections across US Hospitals
por: Mocarski, Michelle, et al.
Publicado: (2014)

Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China
por: Zhang, Hui, et al.
Publicado: (2018)

Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections
por: Tabak, Ying P., et al.
Publicado: (2020)

In vitro activity of ceftazidime-avibactam against Gram-negative strains in patients with complicated urinary tract infection and complicated intra-abdominal infection in Colombia 2014-2018
por: Lemos-Luengas, Elkin V., et al.
Publicado: (2022)

Gram-negative bacteremia is an independent predisposing factor for critical illness polyneuromyopathy
por: Kritikos, K, et al.
Publicado: (2007)

1,4,5,8-Tetra-n-butylanthracene
por: Kitamura, Chitoshi, et al.
Publicado: (2010)

Carbapenem vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts by Propensity Score
por: Rajagopal, Sumanth, et al.
Publicado: (2017)

216. Association Between Days to Initiate Appropriate Therapy and Hospital Length of Stay Among Adult Hospitalized Patients With Gram-negative Bloodstream Infections (GN-BSI)
por: Lodise, Thomas, et al.
Publicado: (2019)

Epidemiology of Carbapenem-Resistant Enterobacteriaceae Bacteremia in Gyeonggi Province, Republic of Korea, between 2018 and 2021
por: Lee, Seung Hye, et al.
Publicado: (2023)

Risk Factors and Outcome Analysis of Gram-Positive Bacteremia in Critically Ill Patients
por: Singh, Navpreet, et al.
Publicado: (2023)

Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia
por: Abe, Ryuzo, et al.
Publicado: (2010)

Use of urinary gram stain for detection of urinary tract infection in childhood.
por: Arslan, Sükrü, et al.
Publicado: (2002)

Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia
por: Shin, Dong Hoon, et al.
Publicado: (2020)

116. Risk Factors and Clinical Outcomes of Carbapenem Non-Susceptible Gram-Negative Bacteremia in Patients with Acute Myelogenous Leukemia
por: Hoon Shin, Dong, et al.
Publicado: (2019)

Carbapenemase-Producing Gram-Negative Bacteria in Andalusia, Spain, 2014–2018
por: López-Hernández, Inmaculada, et al.
Publicado: (2020)

Evaluating Children with Otitis Media for Bacteremia or Urinary Tract Infection
por: Yawman, Daniel, et al.
Publicado: (2010)

Predictive factors for bacteremia in febrile infants with urinary tract infection
por: Yoon, Seo Hee, et al.
Publicado: (2020)

Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria
por: Charles, Pierre Emmanuel, et al.
Publicado: (2008)

Characterization of carbapenem-resistant gram-negative bacteria collected in the Sentinel Surveillance Program, 2018–2019
por: Spicer, Lori, et al.
Publicado: (2022)

In vitro Activity of Cefiderocol against Globally Collected Carbapenem-Resistant Gram-Negative Bacteria Isolated from Urinary Track Source: SIDERO-CR-2014/2016
por: Tsuji, Masakatsu, et al.
Publicado: (2017)

PB2285: CLINICAL EXPERIENCE WITH CEFTAZIDIME-AVIBACTAM FOR THE TREATMENT OF BACTEREMIA DUE TO CARBAPENEM-RESISTANT GRAM-NEGATIVE BACTERIA IN HEMATOLOGIC PATIENTS
por: Zhen, S., et al.
Publicado: (2022)

Bacteremia due to carbapenem-resistant Citrobacter braakii
por: Prasanna, Vardhan, et al.
Publicado: (2022)

211. Disease burden of bacteremia with extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae in Korea
por: Mi Lee, Chan, et al.
Publicado: (2023)

Contribution of urinary tract infection to the burden of febrile illnesses in young children in rural Kenya
por: Masika, Wechuli Geoffrey, et al.
Publicado: (2017)

Virulence Factors Associated With Escherichia coli Bacteremia and Urinary Tract Infection
por: Kim, Bongyoung, et al.
Publicado: (2022)

Carbapenem resistant Gram-negative bacteremia in an Indian intensive care unit: A review of the clinical profile and treatment outcome of 50 patients
por: Porwal, Ravikant, et al.
Publicado: (2014)

Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy
por: Sathya Kumar, Abi Manesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8n9vkdfdn6206ap5p46eslc32o